FMC: (1S)-1-(7-amino-1H-pyrazolo[4,3-d]pyrimidin-3-yl)-1,4-anhydro-D-ribitol
FMC is a Ligand Of Interest in 4TTJ designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 4TTJ_FMC_A_302 | 52% | 5% | 0.122 | 0.878 | 3.73 | 1.68 | 8 | 3 | 2 | 0 | 100% | 0.65 |
| 4TTJ_FMC_B_302 | 35% | 4% | 0.142 | 0.828 | 3.87 | 1.66 | 8 | 3 | 0 | 0 | 100% | 0.54 |
| 4TTJ_FMC_D_302 | 19% | 4% | 0.171 | 0.771 | 3.94 | 1.74 | 8 | 3 | 0 | 0 | 100% | 0.55 |
| 3UT6_FMC_C_300 | 96% | 33% | 0.053 | 0.968 | 1.28 | 1.29 | 1 | 4 | 4 | 0 | 100% | 1 |
| 4TS9_FMC_A_300 | 87% | 32% | 0.071 | 0.948 | 1.31 | 1.28 | 2 | 3 | 2 | 0 | 100% | 0.77 |
| 4TTA_FMC_D_302 | 52% | 34% | 0.103 | 0.858 | 1.28 | 1.22 | 3 | 2 | 2 | 0 | 100% | 0.67 |
| 6XZ2_FMC_B_301 | 47% | 11% | 0.141 | 0.88 | 1.26 | 2.71 | 2 | 5 | 0 | 0 | 100% | 0.71 |
| 4TTI_FMC_A_300 | 46% | 33% | 0.115 | 0.847 | 1.3 | 1.25 | 3 | 2 | 2 | 0 | 100% | 0.61 |
| 1MRH_FMC_A_300 | 96% | 5% | 0.05 | 0.964 | 2.68 | 2.49 | 8 | 7 | 1 | 0 | 100% | 1 |
| 3NM5_FMC_B_502 | 94% | 14% | 0.055 | 0.96 | 1.68 | 2.1 | 3 | 4 | 2 | 0 | 100% | 1 |
| 1MRK_FMC_A_300 | 92% | 18% | 0.066 | 0.963 | 1.34 | 2.06 | 3 | 7 | 0 | 0 | 100% | 1 |
| 1NC3_FMC_B_234 | 91% | 10% | 0.061 | 0.952 | 2.56 | 1.74 | 8 | 5 | 0 | 0 | 100% | 1 |
| 6F4X_FMC_B_301 | 88% | 5% | 0.067 | 0.948 | 2.47 | 2.79 | 7 | 4 | 0 | 0 | 100% | 1 |